Evidence map›Paper›PMID 38710838›Full record

ArticleNature biomedical engineering2024

Durable lymph-node expansion is associated with the efficacy of therapeutic vaccination.

Alexander J Najibi, Ryan S Lane, Miguel C Sobral, Giovanni Bovone, Shawn Kang, Benjamin R Freedman, Joel Gutierrez Estupinan, Alberto Elosegui-Artola, Christina M Tringides, Maxence O Dellacherie and 5 more

Abstract read
In one paragraph

Article in Nature biomedical engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Antibody feedback establishes an affinity brake in the germinal center.bioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Alexander J NajibiJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.ORCID 0000-0001-7761-392X
Ryan S LaneDepartment of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0002-6788-3560
Miguel C SobralJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Giovanni BovoneWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.
Shawn KangJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Benjamin R FreedmanJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Joel Gutierrez EstupinanJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Alberto Elosegui-ArtolaJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Christina M TringidesJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Maxence O DellacherieJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA.
Katherine WilliamsDepartment of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0001-8061-0105
Hamza IjazWyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA, USA.
Sören MüllerDepartment of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0001-9490-5270
Shannon J TurleyDepartment of Cancer Immunology, Genentech, Inc., South San Francisco, CA, USA.ORCID 0000-0002-0444-3031
David J MooneyJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, MA, USA. mooneyd@seas.harvard.edu.ORCID 0000-0001-6299-1194

Funding

Th1 polarizing immune responses using DNA origamiU54CA244726 · NCI · HARVARD UNIVERSITY · PI HODI, FRANK S, MOONEY, DAVID J · 2019 to 2019
$8.2M
Biomaterial Cancer Vaccines that Generate Patient-Specific Antigen In SituR01CA223255 · NCI · HARVARD UNIVERSITY · PI MOONEY, DAVID J · 2018 to 2022
$2.1M
Multifunctional tough adhesive hydrogels to recruit, expand, and deliver tendoncells during aging and injuryK99AG065495 · NIA · HARVARD UNIVERSITY · PI FREEDMAN, BENJAMIN ROSS · 2020 to 2022
$341k
NCI NIH HHS R01 CA223255NCI NIH HHS U54 CA244726NIA NIH HHS K99 AG065495
6 · The paper itself

Abstract

Following immunization, lymph nodes dynamically expand and contract. The mechanical and cellular changes enabling the early-stage expansion of lymph nodes have been characterized, yet the durability of such responses and their implications for adaptive immunity and vaccine efficacy are unknown. Here, by leveraging high-frequency ultrasound imaging of the lymph nodes of mice, we report more potent and persistent lymph-node expansion for animals immunized with a mesoporous silica vaccine incorporating a model antigen than for animals given bolus immunization or standard vaccine formulations such as alum, and that durable and robust lymph-node expansion was associated with vaccine efficacy and adaptive immunity for 100 days post-vaccination in a mouse model of melanoma. Immunization altered the mechanical and extracellular-matrix properties of the lymph nodes, drove antigen-dependent proliferation of immune and stromal cells, and altered the transcriptional features of dendritic cells and inflammatory monocytes. Strategies that robustly maintain lymph-node expansion may result in enhanced vaccination outcomes.

Indexed as

Lymph NodesMice, Inbred C57BLVaccinationAdaptive ImmunityAnimalsCancer VaccinesDendritic CellsFemaleMiceSilicon DioxideUltrasonographyCancer VaccinesSilicon Dioxide

Identifiers

PMID38710838
PMCPMC11485260

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.